Image
03.02.2023
Research reveals the impact of deprivation on the health of people wit...
Research we funded has revealed people with type 1 diabetes living in socially deprived areas of Scotland...
Diabetes UK https://www.diabetes.org.uk
News & Views
A software upgrade is now available for the FreeStyle LibreLink app which will allow people to use the FreeStyle Libre 2 like a real-time continuous glucose monitor. Find out how to download the update, and what this means for managing your glucose readings.
Showing 189 articles
Image
26.01.2023
Autoantibody testing can help to diagnose diabetes type correctly
New diabetes type research funded by us has highlighted that not everyone with diabetes is diagnosed with...
Image
25.01.2023
Children with type 1 diabetes do as well at school, research shows
Research from Cardiff University reveals that although children with type 1 diabetes miss more school day...
Image
19.01.2023
Closed-loop technology could benefit people with type 2 diabetes
New research shows that closed-loop technology, or an artificial pancreas, holds huge promise for people ...
Image
09.01.2023
Inside the lab: Shape-shifting cells and beta cell transplants
We invest over £6 million every year into new research, to transform the lives of people with diabetes. H...
Image
06.01.2023
We invested over £6 million into new diabetes research in 2022
In 2022, your donations allowed us to commit over £6.2 million to get 30 pioneering new diabetes research...
Image
06.01.2023
Professor Roy Taylor awarded MBE for services to diabetes research
Congratulations to Diabetes UK-funded researcher Professor Roy Taylor, who has been awarded an MBE in the...
Image
22.12.2022
The biggest diabetes research stories of 2022
2022 has been a big year for diabetes research, filled with historic moments and world-firsts. Here we ta...
Image
08.12.2022
Combining immunotherapies can slow down type 1 diabetes, research finds
Our scientists have found that combining two different immunotherapy drugs, called Abatacept and interleu...
Image
17.11.2022
First ever treatment to delay type 1 diabetes is licensed in the US
The US Food and Drugs Administration (FDA) has approved the world’s first ever immunotherapy for type 1 d...
Image
14.11.2022
Open for recruitment: UK-first ELSA study to screen 20,000 children fo...
We’re delighted to announce that a new trial screening programme for type 1 diabetes, the ELSA study, whi...
Image
04.11.2022
Gene therapy could offer new treatments for type 2 diabetes
Research funded by us has revealed how important a particular gene is for controlling how fat is stored i...
Image
01.11.2022
Putting quality of life measures at the heart of diabetes technology r...
Research on diabetes technology often focuses just on its impact on diabetes management. But a new study ...
Image
27.10.2022
Inside the lab: Putting footwear guidelines to the test
We invest around £6.5 million into new diabetes research every single year. This research helps us to lea...
Image
04.10.2022
Flash glucose monitoring transforms lives of people with type 1 diabet...
Research funded by us has revealed the transformational impacts Flash glucose monitoring has on blood sug...
Image
29.09.2022
Highlights from Europe’s largest diabetes conference (EASD)
Diabetes researchers from across the world shared their latest breakthroughs at this year’s annual Europe...
© The British Diabetic Association operating as Diabetes UK, a charity registered in England and Wales (no. 215199) and in Scotland (no. SC039136). A company limited by guarantee registered in England and Wales with (no.00339181) and registered office at Wells Lawrence House, 126 Back Church Lane London E1 1FH
